A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
Sébastien Taurin(University of Otago), Khaled Greish(University of Otago)
Cited by 20
Related Papers
Phosphorylation of β-Catenin by Cyclic AMP-dependent Protein Kinase
|Journal of Biological Chemistry|2006|458
A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme
|Oncotarget|2015|32
A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines
|International Journal of Oncology|2015|13